Search research articles
Contact Us
Filters
Showing results (361-370 of 393) with videos related to
Page
of 40
Sort By:
Cancer Discovery
|
August 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
Meenakshi Anurag, Eric J Jaehnig, Karsten Krug, et al.
Molecular & Cellular Proteomics : MCP
|
February 20, 2015
Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma
Susan E Abbatiello, Birgit Schilling, D R Mani, et al.
Blood Cancer Discovery
|
September 27, 2021
<i>ZBTB33</i> is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing
Ellen M Beauchamp, Matthew Leventhal, Elsa Bernard, et al.
European Journal of Epidemiology
|
July 5, 2022
Proteomics and Population Biology in the Cardiovascular Health Study (CHS): design of a study with mentored access and active data sharing
Thomas R Austin, Caitlin P McHugh, Jennifer A Brody, et al.
Cancer Cell
|
September 24, 2019
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
Romain Guièze, Vivian M Liu, Daniel Rosebrock, et al.
Molecular & Cellular Proteomics : MCP
|
January 21, 2014
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach
Steven A Carr, Susan E Abbatiello, Bradley L Ackermann, et al.
Cell
|
June 25, 2021
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Shira Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 13, 2016
Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays
Jeffrey R Whiteaker, Goran N Halusa, Andrew N Hoofnagle, et al.
Nature Communications
|
April 26, 2017
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
Kuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
Cell
|
April 15, 2025
Precision proteogenomics reveals pan-cancer impact of germline variants
Fernanda Martins Rodrigues, Nadezhda V Terekhanova, Kathleen J Imbach, et al.
Page
of 40
Search research articles
Search
Showing results (361-370 of 393) with videos related to
Sort By:
Page
of 40
Cancer Discovery
|
August 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
Meenakshi Anurag, Eric J Jaehnig, Karsten Krug, et al.
Molecular & Cellular Proteomics : MCP
|
February 20, 2015
Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma
Susan E Abbatiello, Birgit Schilling, D R Mani, et al.
Blood Cancer Discovery
|
September 27, 2021
<i>ZBTB33</i> is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing
Ellen M Beauchamp, Matthew Leventhal, Elsa Bernard, et al.
European Journal of Epidemiology
|
July 5, 2022
Proteomics and Population Biology in the Cardiovascular Health Study (CHS): design of a study with mentored access and active data sharing
Thomas R Austin, Caitlin P McHugh, Jennifer A Brody, et al.
Cancer Cell
|
September 24, 2019
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
Romain Guièze, Vivian M Liu, Daniel Rosebrock, et al.
Molecular & Cellular Proteomics : MCP
|
January 21, 2014
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach
Steven A Carr, Susan E Abbatiello, Bradley L Ackermann, et al.
Cell
|
June 25, 2021
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Shira Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 13, 2016
Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays
Jeffrey R Whiteaker, Goran N Halusa, Andrew N Hoofnagle, et al.
Nature Communications
|
April 26, 2017
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
Kuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
Cell
|
April 15, 2025
Precision proteogenomics reveals pan-cancer impact of germline variants
Fernanda Martins Rodrigues, Nadezhda V Terekhanova, Kathleen J Imbach, et al.
Page
of 40